Caprihans India Limited has informed the Exchange about Standalone & Consolidated Unaudited Financial Results for the quarter ended on 30 June 2026 along with Limited Review Report issued ....

Bilcare Caprihans India Limited Tel +91 20 6749 0100 direct@bilcare.com 601, ICC Trade Towers, www.bilcare.com R.tuearc/t,; Pune 411016 India 10 August 2026 BSE Ltd Dept. of Corporate Services, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400001 Scrip Code No – 509486 Sub: Outcome of Board Meeting Dear Sir/Madam, Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors of the Company at its meeting held on Monday, 10 August 2026 have approved and taken on record the following: A. Standalone and Consolidated Unaudited Financial Results of the Company for the quarter ended on 30 June 2026 (enclosed); B. Limited Review Report issued by the Statutory Auditors of the Company for the quarter ended on 30 June 2026 (enclosed); C. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, this is to inform you that Mr. Avinash S. Joshi (DIN: 05320116) vide communication dated 10 August 2026, has tendered resignation as an Independent Director of the Company, with effect from close of business hours on 10 August 2026. Consequently, he shall also cease to be a Member of the Audit Committee, Nomination and Remuneration Committee and from the Chairmanship of Audit Committee of the Company. The Board place on record its sincere appreciation for the valuable contribution and guidance provided by Mr. Mr. Avinash S. Joshi during his association with the Company as Independent Director of the Company. The details as required under SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015 along with copy of resignation letter are enclosed herewith as Annexure - I. D. In view of the changes in the Board of Directors, the Board has approved the changes in the composition of Audit Committee and Nomination and Remuneration Committee with effect from 11 August 2026. The details are enclosed herewith as Annexure - II. The Board meeting commenced at 06:00 P.M. and concluded at 08:30 P.M. (IST). You are requested to take the same on record and confirm receipt of the same. Thanking you, Yours faithfully, For Caprihans India Limited Rajesh P. Likhite Company Secretary & Compliance Officer Encl: as above Pune Plant & Registered Office: 1028 Shiroli Rajgurunagar Pune 410505 India Tel +91 2135 647300 CIN - L29150PN1946PLC232362  GST 27AAACC1646F1Z0 Caprihans India Limited Registered Office: I 028 Shiroli, Rajgurunagar, Pune 410505 Tel : +9 I 21 35647300 Email : direct@bilcare.com Website : www.bilcare.com CIN : L29150PNl946PLC232362 Unaudited Standalone Statement of Financial Results for the Quarter ended June 30, 2026 (Rs. In Crores) Sr No Particulars Quarter ended Year Ended June 30, March June 30, March 31, 2026 31, 2026 2025 2026 (unaudited) (audited) (unaudited) (audited) I Income (a) Revenue From Operations 216.96 178.85 177.85 697.07 (b) Other Operating Income 3.20 2.96 4.04 13.18 Total Revenue from Operations 220.16 181.81 181.89 710.25 (c) Other Income 1.82 18.41 3.02 27.83 Total Income (I) 221.98 200.22 184.91 738.08 2 Expenses (a) Cost of Materials Consumed 138.53 120.86 126.75 481.3 7 (b) Purchase of Traded Goods - 0.01 0.02 (c) Changes in Inventories or Finished Goods. Work-in-Progress (3.48) (7.58) (2.62) (4.29) (d) Employee Benefits Expense 17.80 17.-i8 17.94 70.88 (e) Finance Costs 18.67 18.24 19.05 74.40 (t) Depreciation and Amortisation Expense 10.76 11.14 10.93 44.90 (g) Other Expenses 32.69 33.84 30.51 121. 78 Total Expenses (2) 214.97 193.99 202.56 789.06 3 Profit/(Loss) Before Exceptional Items and Tax (1-2) 7.01 6.23 ( 17.65) (50.98) 4 Exceptional Item Net (Expense)/lncome - 0.08 - ( 1.64) 5 Profit/(Loss) Before Tax after Exceptional Item (3+4) 7.01 6.31 ( 17.65) (52.62) 6 Tax Expense (a) Current Tax - - - - (b) Adjustment of Tax Relating to Earlier Years - - - - (c) Deferred Tax - - (4. 10) (4.45) Total Tax Expense (6) - - (4.10) (4.45) 7 Profit/(Loss) for the Period (5-6) 7.01 6.31 ( 13.55) (48.17) 8 Other Comprehensive Income a. Items that will not be reclassified to Profit or Loss (i) Remeasurement Gain/(Losses) on Defined Benefit Plans ( 1.07) (0.84) (0.17) 2.27 (ii)Tax Impact - - 0.04 0.12 Total Other Comprehensive Income (8) (1.07) (0.84) (0.13) 2.39 9 Total Comprehensive Income for the Period (7+8) 5.94 5.47 ( 13.68) (45.78) 10 Paid-up Equity Share Capital ( Face Value of Rs 10 Per Share) 17.62 15.91 14.62 15.91 11 Reserves Excluding Revaluation Reserves as Per The Balance Sheet of The Respective Accounting Year - - - (169.93) 12 Earnings per Share (Not A ·" -1) - Basic EPS (Amount in R~-<._& ~S~o#\ 4.25 4.31 (9.27) (32.88) Diluted EPS (Amount i~ ~ ~ #c.,\NO& 3.98 3.52 (9.27) (32.88) t 1s ~ cl ...., ~ "red Acc0,s o,, ., ........... /,,-0 Caprihans India Limited Registered Office: 1028 Shiroli, Rajgurunagar, Pune 410505 Tel : +91 21 35647300 Email : direct@bilcare.com Website: www.bilcare.com CIN : L29150PN1946PLC232362 Notes to Standalone Financial Results: 1 The Company is primarily engaged in Pharma Packaging Solutions, and its products are covered under a single reportable segment. 2 The above results have been prepared in accordance with Indian Accounting Standards ( "Ind AS") prescribed under section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 3 Bilcare Research GmbH a wholly owned subsidiary of the Company has been consolidated in the Consolidated financial results of the Group for the period ended June 30, 2026. 4 During the financial year ending March 31, 2025, the Company on 3rd and 5th December 2024 had approved for issue and allotment of 48,00,000 Convertible Warrants (hereinafter referred to as "Warrants") at an issue price of Rs. 200/-each on a preferential basis for an aggregate amount of Rs. 96.00 Crores, against receipt of Rs.24.00 crores as Warrant Subscription; amount being equivalent to 25% of the total consideration, with each Warrant convertible into one equity share of the Company within a period of 18 months from the date of allotment of Warrants at a conversion price of Rs.200/ per Warrant (including Rs. 190 per share towards share premium), to the Allottees ("Allottees") of share warrant. As on 31st March 2026, the company had 20,20,000 warrants outstanding, for which Rs.10.10 Crores had been received as warrant subscription amount. During the quarter ended, June 2026 the company received INR 25.58 Crores being 75% of the 17,05,000 outstanding warrants. Conversion option attached to 3,15,000 share warrants were not exercised within 18 months from the date of allotment i.e. 05th December 2024; hence, the Board of Directors of the Company in the meeting dated 05th June 2026 has approved the forfeiture of the money received of Rs.1.58 Crores from the share warrant holders which has been transferred to capital reserve. 5 During the year, the Company has redeemed 2,55,75,500 0.1% Redeemable Preference Shares (RPS) of Rs. 10/-each issued to Bilcare Limited and the same stands reduced to the equivalent amount 6 In respect of the arrangement with Bilcare Limited (Bilcare) for the repayment of principal and interest on the public fixed deposit liability taken over by the Company as per the Business Transfer Agreement, the outstanding as at June 30, 2026 is Rs. 2.34 crores (including interest) which was fully earmarked and maintained with PFD Escrow account. In respect of these PFDs, Bilcare had received an order from the National Company Law Tribunal, Mumbai, dated 05th June 2026, directing Bilcare to transfer the outstanding amount to the Investor Education and Protection Fund on or before 15th July 2026 and to publish an advertisement/ notice of the same in vernacular and English newspapers. Accordingly, the outstanding amount has been transferred to the Investor Education and Protection Fund and the statutory compl [Showing first 8,000 characters — download PDF for full document]